XpresSpa Group, Inc. (XSPA) Reaches $0.93 52 Week Low; 3 Analysts Bullish Abcam Plc (LON:ABC)

February 13, 2018 - By Clifton Ray

Among 10 analysts covering Abcam PLC (LON:ABC), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Abcam PLC had 71 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by JP Morgan on Thursday, January 12 with “Neutral”. The company was maintained on Monday, March 7 by Peel Hunt. The stock has “Sell” rating by Panmure Gordon on Monday, September 11. Peel Hunt maintained the stock with “Hold” rating in Tuesday, October 31 report. The firm earned “Neutral” rating on Tuesday, March 7 by JP Morgan. The firm has “Hold” rating given on Tuesday, March 7 by Numis Securities. The company was maintained on Tuesday, September 12 by Numis Securities. On Monday, September 11 the stock rating was maintained by Peel Hunt with “Hold”. Numis Securities maintained Abcam Plc (LON:ABC) on Tuesday, January 10 with “Add” rating. The stock has “Buy” rating by Berenberg on Monday, September 11. See Abcam Plc (LON:ABC) latest ratings:

01/02/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 1100.00 New Target: GBX 1100.00 Maintain
22/01/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 1100.00 New Target: GBX 1100.00 Maintain
15/01/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 1020.00 New Target: GBX 1100.00 Maintain
08/01/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 946.00 New Target: GBX 946.00 Maintain
05/01/2018 Broker: Berenberg Rating: Buy New Target: GBX 1240.00 Maintain
05/01/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 1020.00 New Target: GBX 1020.00 Maintain
05/01/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1200.00 Upgrade
29/11/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 1020.00 New Target: GBX 1020.00 Maintain
31/10/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 1020.00 New Target: GBX 1020.00 Maintain
20/09/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 750.00 New Target: GBX 1020.00 Maintain

The stock of XpresSpa Group, Inc. (NASDAQ:XSPA) hit a new 52-week low and has $0.85 target or 9.00% below today’s $0.93 share price. The 9 months bearish chart indicates high risk for the $24.69M company. The 1-year low was reported on Feb, 13 by Barchart.com. If the $0.85 price target is reached, the company will be worth $2.22 million less. The stock decreased 1.06% or $0.01 during the last trading session, reaching $0.93. About 23,896 shares traded. XpresSpa Group, Inc. (NASDAQ:XSPA) has 0.00% since February 13, 2017 and is . It has underperformed by 16.70% the S&P500.

XpresSpa Group, Inc. operates as a health and wellness firm in the United States and internationally. The company has market cap of $24.69 million. It offers spa services, as well as luxury travel products and accessories to air travelers. It currently has negative earnings. The firm was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018.

The stock increased 1.49% or GBX 18 during the last trading session, reaching GBX 1223. About 241,287 shares traded. Abcam Plc (LON:ABC) has 0.00% since February 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company has market cap of 2.50 billion GBP. The firm primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. It has a 59.08 P/E ratio. The Company’s products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery services and products.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>